HDAC inhibitor Pracinostat, Purity ≥98%

Cat. No.: X23-10-ZQ323

HDAC inhibitor Pracinostat, Purity ≥98%

Synonym: 929016-96-6; Pracinostat; SB939; SB 939; Pracinostat (SB939); SB-939; Pracinostat [INN]; HDAC inhibitor

  • MDL: MFCD17215206
  • CAS Number: 929016-96-6
  • Compound CID: 49855250
Product Size
5 mg; 10 mg; 25 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
Pracinostat, soluble in DMSO and ethanol and insoluble in water, induces DNA damage and the inhibition of DNA repair processes. It targets HDAC1, HDAC10, HDAC11, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, and HDAC9.
Molecular Weight
358.5
Molecular Formula
C20H30N4O2
Targets
HDAC1: 49 nM; HDAC10: 40 nM; HDAC11: 93 nM; HDAC2: 96 nM; HDAC3: 43 nM; HDAC4: 56 nM; HDAC5: 47 nM; HDAC6: 1.008 μM; HDAC7: 137 nM; HDAC8: 137 nM; HDAC9: 70 nM
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 68 mg/mL (189.68 mM); Water: Insoluble; Ethanol: 26 mg/mL (72.52 mM)
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
Pracinostat is used in research for its role in inhibiting HDACs, particularly in chronic myelomonocytic leukemia (CMML).
Storage
Store at -20ºC.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.